What are the differences on the use of pharmacological approach on behavioural and cognitive ability of people living with dementia in both community and residential aged care facilities during the covid lockdown isolation while evaluating its effectiveness?
What are the differences on the use of pharmacological approach on behavioural and cognitive ability of people living with dementia in both community and residential aged care facilities during the covid lockdown isolation while evaluating its effectiveness?